𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transitory marrow aplasia during Imatinib therapy in a patient with chronic myeloid leukemia

✍ Scribed by Giulia Cervetti; Giovanni Carulli; Sara Galimberti; Antonio Azzarà; Gabriele Buda; Enrico Orciuolo; Matteo Pelosini; Mario Petrini

Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
119 KB
Volume
32
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imatinib mesylate therapy reduces bone m
Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia
✍ Carlos E. Bueso-Ramos; Jorge Cortes; Moshe Talpaz; Susan O'Brien; Francis Giles; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 1 views

## Abstract ## BACKGROUND Reticulin‐stained bone marrow fibrosis is associated with a poor prognosis in patients with chronic myelogenous leukemia (CML). Resolution of fibrosis with therapy may improve patient outcome. ## METHODS The effect of imatinib therapy on bone marrow fibrosis was evaluat